# Primeenergy Resources Corp: financial statements, quarterly

PNRG · Nasdaq · CIK 56868 · [Energy](/sectors/energy.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pnrg.md) · [Financials](/companies/pnrg/financials.md) · [Filings](/companies/pnrg/filings.md) · [Insiders](/companies/pnrg/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/pnrg/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [37.6](/filings/0001437749-24-035107.md) | [36.7 d](/filings/0001437749-25-012086.md) | [43.0](/filings/0001437749-25-017614.md) | [64.8](/filings/0001437749-25-027372.md) | [69.5](/filings/0001437749-25-035729.md) | [60.5 d](/filings/0001437749-26-012531.md) | [50.1](/filings/0001437749-26-017864.md) | [42.0](/filings/0001437749-26-027969.md) | [46.0](/filings/0001437749-25-035729.md) | [51.0 d](/filings/0001437749-26-012531.md) | [39.4](/filings/0001437749-26-017864.md) | [42.5](/filings/0001437749-26-027969.md) |
| Cost of revenue | $m | [3.2](/filings/0001437749-24-035107.md) | [2.0 d](/filings/0001437749-25-012086.md) | [2.8](/filings/0001437749-25-017614.md) | [2.5](/filings/0001437749-25-027372.md) | [3.1](/filings/0001437749-25-035729.md) | [0.7 d](/filings/0001437749-26-012531.md) | [1.9](/filings/0001437749-26-017864.md) | [1.2](/filings/0001437749-26-027969.md) | [2.0](/filings/0001437749-25-035729.md) | [1.1 d](/filings/0001437749-26-012531.md) | [1.2](/filings/0001437749-26-017864.md) | [1.4](/filings/0001437749-26-027969.md) |
| Operating income | $m | [13.1](/filings/0001193125-23-279768.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [0.1](/filings/0001437749-24-035107.md) | not reported | [0.2](/filings/0001437749-24-017481.md) | [0.2](/filings/0001437749-24-026602.md) | [0.4](/filings/0001437749-24-035107.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [2.4](/filings/0001437749-24-035107.md) | [0.3 d](/filings/0001437749-25-012086.md) | [3.0](/filings/0001437749-25-017614.md) | [4.9](/filings/0001437749-25-027372.md) | [6.0](/filings/0001437749-25-035729.md) | [1.8 d](/filings/0001437749-26-012531.md) | [2.2](/filings/0001437749-26-017864.md) | [1.0](/filings/0001437749-26-027969.md) | [2.7](/filings/0001437749-25-035729.md) | [(1.7) d](/filings/0001437749-26-012531.md) | [0.9](/filings/0001437749-26-017864.md) | [1.5](/filings/0001437749-26-027969.md) |
| Net income | $m | [10.7](/filings/0001437749-24-035107.md) | [5.9 d](/filings/0001437749-25-012086.md) | [11.3](/filings/0001437749-24-035107.md) | [19.7](/filings/0001437749-24-035107.md) | [22.1](/filings/0001437749-24-035107.md) | [2.3 d](/filings/0001437749-26-012531.md) | [9.1](/filings/0001437749-26-027969.md) | [3.2](/filings/0001437749-26-027969.md) | [10.6](/filings/0001437749-25-035729.md) | [3.4 d](/filings/0001437749-26-012531.md) | [4.3](/filings/0001437749-26-027969.md) | [6.5](/filings/0001437749-26-027969.md) |
| Diluted EPS | $ per share | [4.13](/filings/0001437749-24-035107.md) | not reported | [4.41](/filings/0001437749-25-017614.md) | [7.77](/filings/0001437749-25-027372.md) | [8.80](/filings/0001437749-25-035729.md) | not reported | [3.72](/filings/0001437749-26-017864.md) | [1.33](/filings/0001437749-26-027969.md) | [4.38](/filings/0001437749-25-035729.md) | not reported | [1.82](/filings/0001437749-26-017864.md) | [2.75](/filings/0001437749-26-027969.md) |
| Basic EPS | $ per share | [5.84](/filings/0001437749-24-035107.md) | not reported | [6.27](/filings/0001437749-25-017614.md) | [11.08](/filings/0001437749-25-027372.md) | [12.63](/filings/0001437749-25-035729.md) | not reported | [5.40](/filings/0001437749-26-017864.md) | [1.94](/filings/0001437749-26-027969.md) | [6.41](/filings/0001437749-25-035729.md) | not reported | [2.67](/filings/0001437749-26-017864.md) | [4.06](/filings/0001437749-26-027969.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [19.8](/filings/0001193125-23-279768.md) | [11.1](/filings/0001437749-25-012086.md) | [1.8](/filings/0001437749-24-017481.md) | [2.0](/filings/0001437749-24-026602.md) | [1.6](/filings/0001437749-24-035107.md) | [2.5](/filings/0001437749-26-012531.md) | [2.1](/filings/0001437749-25-017614.md) | [2.4](/filings/0001437749-25-027372.md) | [3.7](/filings/0001437749-25-035729.md) | [7.4](/filings/0001437749-26-027969.md) | [19.4](/filings/0001437749-26-017864.md) | [28.7](/filings/0001437749-26-027969.md) |
| Current assets | $m | [37.6](/filings/0001193125-23-279768.md) | [31.8](/filings/0001437749-25-012086.md) | [32.1](/filings/0001437749-24-017481.md) | [48.9](/filings/0001437749-24-026602.md) | [37.0](/filings/0001437749-24-035107.md) | [28.3](/filings/0001437749-26-012531.md) | [28.0](/filings/0001437749-25-017614.md) | [33.2](/filings/0001437749-25-027372.md) | [24.0](/filings/0001437749-25-035729.md) | [27.7](/filings/0001437749-26-027969.md) | [40.9](/filings/0001437749-26-017864.md) | [49.3](/filings/0001437749-26-027969.md) |
| Total assets | $m | [254](/filings/0001193125-23-279768.md) | [289](/filings/0001437749-25-012086.md) | [333](/filings/0001437749-24-017481.md) | [335](/filings/0001437749-24-026602.md) | [346](/filings/0001437749-24-035107.md) | [325](/filings/0001437749-26-012531.md) | [339](/filings/0001437749-25-017614.md) | [343](/filings/0001437749-25-027372.md) | [332](/filings/0001437749-25-035729.md) | [324](/filings/0001437749-26-027969.md) | [322](/filings/0001437749-26-017864.md) | [315](/filings/0001437749-26-027969.md) |
| Current liabilities | $m | [41.7](/filings/0001193125-23-279768.md) | [64.8](/filings/0001437749-25-012086.md) | [88.5](/filings/0001437749-24-017481.md) | [80.5](/filings/0001437749-24-026602.md) | [68.0](/filings/0001437749-24-035107.md) | [49.7](/filings/0001437749-26-012531.md) | [57.5](/filings/0001437749-25-017614.md) | [55.3](/filings/0001437749-25-027372.md) | [45.3](/filings/0001437749-25-035729.md) | [37.4](/filings/0001437749-26-027969.md) | [38.7](/filings/0001437749-26-017864.md) | [33.2](/filings/0001437749-26-027969.md) |
| Total liabilities | $m | [97.6](/filings/0001193125-23-279768.md) | [128](/filings/0001437749-25-012086.md) | [163](/filings/0001437749-24-017481.md) | [148](/filings/0001437749-24-026602.md) | [142](/filings/0001437749-24-035107.md) | [122](/filings/0001437749-26-012531.md) | [134](/filings/0001437749-25-017614.md) | [138](/filings/0001437749-25-027372.md) | [118](/filings/0001437749-25-035729.md) | [108](/filings/0001437749-26-027969.md) | [105](/filings/0001437749-26-017864.md) | [96.9](/filings/0001437749-26-027969.md) |
| Long-term debt | $m | [0.0](/filings/0001193125-23-279768.md) | [0.0](/filings/0001437749-25-012086.md) | [4.0](/filings/0001437749-24-017481.md) | not reported | [3.0](/filings/0001437749-24-035107.md) | [4.0](/filings/0001437749-26-012531.md) | [6.5](/filings/0001437749-25-017614.md) | [12.0](/filings/0001437749-25-027372.md) | [0.0](/filings/0001437749-25-035729.md) | [0.0](/filings/0001437749-26-027969.md) | not reported | [0.0](/filings/0001437749-26-027969.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [156](/filings/0001437749-24-035107.md) | [161](/filings/0001437749-26-012531.md) | [169](/filings/0001437749-25-027372.md) | [186](/filings/0001437749-25-035729.md) | [204](/filings/0001437749-25-035729.md) | [203](/filings/0001437749-26-027969.md) | [205](/filings/0001437749-26-027969.md) | [205](/filings/0001437749-26-027969.md) | [214](/filings/0001437749-25-035729.md) | [216](/filings/0001437749-26-027969.md) | [217](/filings/0001437749-26-027969.md) | [218](/filings/0001437749-26-027969.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [35.3 d](/filings/0001437749-24-035107.md) | [38.3 d](/filings/0001437749-25-012086.md) | [43.2](/filings/0001437749-25-017614.md) | [(1.9) d](/filings/0001437749-25-027372.md) | [50.8 d](/filings/0001437749-25-035729.md) | [23.9 d](/filings/0001437749-26-012531.md) | [38.2](/filings/0001437749-26-017864.md) | [(8.3) d](/filings/0001437749-26-027969.md) | [54.7 d](/filings/0001437749-25-035729.md) | [12.2 d](/filings/0001437749-26-012531.md) | [16.1](/filings/0001437749-26-017864.md) | [15.4 d](/filings/0001437749-26-027969.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | [34.7](/filings/0001437749-26-017864.md) | [(6.0) d](/filings/0001437749-26-027969.md) | not reported | not reported | [1.5](/filings/0001437749-26-017864.md) | [0.7 d](/filings/0001437749-26-027969.md) |
| Share repurchases | $m | [1.2 d](/filings/0001437749-24-035107.md) | [0.9 d](/filings/0001437749-25-012086.md) | [2.8](/filings/0001437749-25-017614.md) | [2.9 d](/filings/0001437749-25-027372.md) | [4.5 d](/filings/0001437749-25-035729.md) | [3.2 d](/filings/0001437749-26-012531.md) | [7.1](/filings/0001437749-26-017864.md) | [2.9 d](/filings/0001437749-26-027969.md) | [2.0 d](/filings/0001437749-25-035729.md) | [1.5 d](/filings/0001437749-26-012531.md) | [2.6](/filings/0001437749-26-017864.md) | [5.5 d](/filings/0001437749-26-027969.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [2,695](/filings/0001193125-23-279768.md) | [2,647](/filings/0001437749-24-017481.md) | [2,644](/filings/0001437749-24-026602.md) | [2,594](/filings/0001437749-24-035107.md) | [2,566](/filings/0001437749-25-017614.md) | [2,540](/filings/0001437749-25-027372.md) | [2,509](/filings/0001437749-25-035729.md) | [2,456](/filings/0001437749-26-017864.md) | [2,425](/filings/0001437749-26-027969.md) | [2,411](/filings/0001437749-25-035729.md) | [2,388](/filings/0001437749-26-017864.md) | [2,372](/filings/0001437749-26-027969.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 1,582,600 at 2026-08-14, from the cover of the [10-Q filed 2026-08-14](/filings/0001437749-26-027969.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:19 ET. No prices; not investment advice.